Precision BioSciences offers high-risk, high-reward potential, trading below cash with key HBV and DMD data catalysts ...
One of the most challenging moments in cancer treatment comes when a therapy stops working. In many metastatic cancers, drugs ...
This study offers important insight into the pathogenic basis of intragenic frameshift deletions in the carboxy-terminal domain of MECP2, which account for some Rett syndrome cases, yet similar ...
Three start-ups are aiming to create gene-edited babies. Columnist Michael Le Page has no doubt that editing our offspring ...
Live Science on MSNOpinion
From gene therapy breakthroughs to preventable disease outbreaks: The health trends that will shape 2026
Live Science's health channel editor makes predictions about the medical breakthroughs and public health shifts to come in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback